Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 2/20 | 0.40 |
| ▸ | LIPG | Q9Y5X9 | 2/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.34 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.34 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24328625 | 0.91 | LPL (0.49) | LPLLIPGESR1ESR2PRMT5 | |
| SCHEMBL24328655 | 0.87 | ESR1 (0.31) | ESR1ESR2 | |
| SCHEMBL24329344 | 0.87 | LPL (0.39) | LPLLIPGPRMT5WDR77 | |
| SCHEMBL2618788 | 0.86 | LIPG (0.47) | LPLLIPGESR1ESR2PRMT5 | |
| SCHEMBL29892359 | 0.86 | LIPG (0.47) | LPLLIPGESR1ESR2PRMT5 | |
| SCHEMBL23349181 | 0.84 | LIPG (0.45) | LPLLIPGESR1ESR2PRMT5 | |
| SCHEMBL24328673 | 0.83 | LIPG (0.40) | LPLLIPGESR1ESR2PRMT5 | |
| SCHEMBL16577936 | 0.83 | LIPG (0.42) | LPLLIPGESR1ESR2PRMT5 | |
| SCHEMBL15937417 | 0.82 | LIPG (0.51) | LPLLIPGPRMT5WDR77 | |
| SCHEMBL20127200 | 0.82 | LIPG (0.43) | LPLLIPGKDM4EMEN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11299466-B2 | Compound, and organic electronic element comprising same | LG CHEM, LTD. | 2022-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11299466-B2 | Compound, and organic electronic element comprising same | OR10J3, ETV6, ODC1 | LPL 4248/4885LIPG 3342/4885ESR1 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.